Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 25.25
+0.65 (2.64%)
Sep 18, 2025, 12:49 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.63 billion as of September 18, 2025. Its market cap has decreased by -1.88% in one year.
Market Cap
1.63B
Enterprise Value
1.54B
Revenue
123.19M
Ranking
n/a
PE Ratio
59.74
Stock Price
25.25
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.63B, an increase of 21,529.57%. That is a compound annual growth rate of 36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 1.63B | 0.50% |
| Dec 30, 2024 | 1.62B | -52.50% |
| Dec 29, 2023 | 3.40B | 13.17% |
| Dec 30, 2022 | 3.01B | -37.05% |
| Dec 30, 2021 | 4.78B | 131.75% |
| Dec 30, 2020 | 2.06B | 30.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.86B |
| Sectra AB | 60.54B |
| Getinge AB | 57.69B |
| Camurus AB | 40.94B |
| Medicover AB | 39.86B |
| Asker Healthcare Group AB | 36.24B |
| BioArctic AB | 23.97B |
| AddLife AB | 22.86B |